Raloxifene (Keoxifene, Pharoxifene, LY-139481, LY-156758, CCRIS-7129) is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women.
[1] Obach RS, et al. Drug Metab Dispos, 2004, 32(1), 89-97.
















